Neutra Corp. (OTC: NTRR), an early-stage research and development company, is preparing to launch a new transdermal, hemp-based sports cream intended to provide pain relief for athletes whose workouts induce aches and pains. An article discussing the company reads, “The cream rollout is the latest product to market created under Neutra’s subsidiary VIVIS Corp., an emerging retail brand of hemp-based health and nutritional products acquired last month as Neutra’s retail presence. Vivis has a line of products that features a 99% or higher grade of hemp-extracted crystalline CBD, and a second product line in the works will feature an 80% or higher grade of full-spectrum CBD extract. . . . ‘We’re now seeing the positive payoff of hiring a dedicated sports-medicine advisor earlier this year,’ CEO Sydney Jim stated in a news release about the sports-cream development (http://cnw.fm/tLR2h). ‘Our goal with that hire was to develop hemp-based CBD (cannabidiol) products geared to the expanding sports market. VIVIS’ upcoming transdermal sports cream will appeal to the rapidly growing number of active Americans wanting to improve performance, relieve aches and pains, prevent injuries and lead healthier lifestyles.’”
To view the full article, visit http://cnw.fm/15Mx5
About Neutra Corp.
Neutra Corp. is an early-stage research and development company with a focus on bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental-purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the thriving hemp-based CBD market, in which Neutra Corp. intends to participate. For more information, visit the company’s website at www.NeutraInc.com.
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com